TRT and Polycythemia: Managing High Hematocrit

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Polycythemia, characterized by an abnormally high red blood cell count (hematocrit), is a common side effect of testosterone replacement therapy (TRT). While often manageable, it can increase the risk of blood clots and cardiovascular events, necessitating careful monitoring and proactive management strategies to ensure patient safety.

TRT and Polycythemia: Understanding and Managing High Hematocrit

For men undergoing testosterone replacement therapy (TRT), one of the most frequently encountered side effects is polycythemia, also known as erythrocytosis. This condition is characterized by an increase in the red blood cell count, leading to a higher hematocrit level—the percentage of red blood cells in your blood. While often manageable, it's a critical parameter to monitor, as significantly elevated hematocrit can increase the risk of serious cardiovascular events, including blood clots, heart attacks, and strokes.

Why Does TRT Cause Polycythemia?

Testosterone naturally stimulates erythropoiesis, the production of red blood cells, primarily by increasing the kidney's production of erythropoietin (EPO). This is why men typically have higher red blood cell counts than women. When exogenous testosterone is introduced via TRT, this stimulatory effect is amplified. The degree to which hematocrit increases can vary significantly among individuals and depends on several factors, including:

• Route of Administration: Injectable testosterone, particularly longer-acting esters like testosterone cypionate or enanthate, is more commonly associated with higher hematocrit levels compared to transdermal gels or patches (Shin et al., 2016). This is often due to the supraphysiological peaks in testosterone levels that can occur after an injection.
• Dosage and Frequency: Higher doses and less frequent injections can lead to greater fluctuations in testosterone levels, potentially exacerbating erythropoiesis.
• Individual Sensitivity: Some men are simply more prone to developing polycythemia on TRT than others.
• Pre-existing Conditions: Factors like sleep apnea, obesity, and smoking can also contribute to elevated hematocrit, and these can be exacerbated by TRT.

Monitoring Hematocrit on TRT: What to Watch

Regular monitoring of hematocrit (and hemoglobin) is a cornerstone of safe TRT management. Your doctor will typically check these levels:

• Baseline: Before starting TRT, to establish your individual baseline.
• Initial Follow-up: At 3 to 6 months after initiating therapy, to assess the initial response.
• Ongoing: Every 6 to 12 months thereafter, or more frequently if levels are trending upwards or if you're experiencing symptoms.

The goal is generally to keep hematocrit below 52% to 54%. Exceeding this threshold can significantly increase the risk of hyperviscosity, where the blood becomes thicker, making it harder for the heart to pump and increasing the likelihood of clot formation.

Management Strategies for High Hematocrit

If your hematocrit levels become too high, your doctor will implement strategies to bring them back into a safe range. These may include:

• Dose Adjustment: Reducing the dose of testosterone is often the first step. For example, if you're on 200mg every two weeks, your doctor might reduce it to 100mg every week, or even 50mg twice a week, to maintain more stable testosterone levels and avoid high peaks.
• Change in Administration Route: Switching from injectable testosterone to a transdermal gel or patch can often help, as these methods typically produce more stable, physiological testosterone levels with less erythropoietic stimulation.
• Therapeutic Phlebotomy: This involves drawing a unit of blood, similar to blood donation, to reduce the red blood cell count. It's a highly effective method for rapidly lowering hematocrit and is often used when levels are acutely elevated or if dose adjustments aren't sufficient. The frequency of phlebotomy depends on the individual's response and hematocrit levels.
• Addressing Contributing Factors: Managing underlying conditions like sleep apnea, obesity, or smoking cessation can also help reduce hematocrit.

Unlike some other TRT side effects, polycythemia is usually reversible and highly manageable with appropriate intervention. It's a testament to the importance of a knowledgeable practitioner overseeing your therapy.

Practical Takeaway

Polycythemia is a common and manageable side effect of TRT, but it's not something to ignore. You'll need regular blood tests to monitor your hematocrit levels, typically every 6-12 months. If your hematocrit rises above 52-54%, your doctor will work with you to adjust your testosterone dose, change your administration method, or recommend therapeutic phlebotomy to keep your blood healthy and reduce your risk of blood clots. Don't hesitate to discuss any symptoms like fatigue, headaches, or dizziness, as these can be signs of elevated hematocrit.